RxDoctor Payments Data

Jaydevsinh Dolia, MD

Vascular Neurology · Atlanta, GANPI 1437562980

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medical Device Business Services, Inc. at 40.0% of the total. 2025 is the largest year on record at $13,278, 8.2 times the $1,625 reported in 2019.

$24,520in general payments, 2019–2025

Across 102 payments — averaging $240.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$10K
  • Balt USA, LLC$5K
  • Perfuze Limited$5K
  • Stryker$1K
  • Penumbra, Inc.$1K
  • Microvention, Inc.$865
  • plus $1K from 10 others
$336,663in research payments, 2019–2025

Across 16 payments — averaging $21,041 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$337K

What the payments were for

  • Consulting fees$14,50559%
  • Travel & lodging$6,89828%
  • Food & beverage$3,11713%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$26,366
Medicare patients
48
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular neurology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →